TAŞTEKİN, D. Et Al. 2023. Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience. Journal of Cancer Research and Therapeutics , vol.19, no.2 , 253-258.

TAŞTEKİN, D., PAKSOY, N., Dogan, I., Ferhatoglu, F., Khanmammadov, N., Bozbey, H. U., ... KARABULUT, S.(2023). Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience. Journal of Cancer Research and Therapeutics , vol.19, no.2, 253-258.

TAŞTEKİN, Didem Et Al. "Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience," Journal of Cancer Research and Therapeutics , vol.19, no.2, 253-258, 2023

TAŞTEKİN, Didem Et Al. "Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience." Journal of Cancer Research and Therapeutics , vol.19, no.2, pp.253-258, 2023

TAŞTEKİN, D. Et Al. (2023) . "Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience." Journal of Cancer Research and Therapeutics , vol.19, no.2, pp.253-258.

@article{article, author={Didem TAŞTEKİN Et Al. }, title={Fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) regimen in the first-line treatment of metastatic gastric cancer: A single-center experience}, journal={Journal of Cancer Research and Therapeutics}, year=2023, pages={253-258} }